17-Epiestriol, an Estrogen Metabolite, Is More Potent Than Estradiol in Inhibiting Vascular Cell Adhesion Molecule 1 (VCAM-1) mRNA Expression
Open Access
- 1 April 2003
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 278 (14), 11746-11752
- https://doi.org/10.1074/jbc.m207800200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- NO Inhibits Cytokine-Induced iNOS Expression and NF-κB Activation by Interfering With Phosphorylation and Degradation of IκB-αArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen ReceptorEndocrinology, 1998
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- ESTROGENS AND ATHEROSCLEROSISAnnual Review of Pharmacology and Toxicology, 1997
- Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and RaloxifeneScience, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.JCI Insight, 1995
- Estradiol-17β regulates the induction of VCAM-1 mRNA expression by interleukin-1β in human umbilical vein endothelial cellsLife Sciences, 1994
- Modulation of AP‐1 activity by nitric oxide (NO) in vitro: NO‐mediated modulation of AP‐1FEBS Letters, 1994